This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Phlyctenular conjunctivitis

Authoring team

  • this is a delayed hypersensitivity reaction to microbial proteins - e.g. the tubercle bacillus, staphylococcus, chlamydia yeasts and Candida albicans. It occurs in undernourished children living in overcrowded, unhygienic conditions

  • clinical features:
    • the major feature are phlyctens - raised hard red, 1-3mm, nodules near the limbus and accompanied by a zone of hyperemia. There is a tendency to ulcerate and disappear, but frequently, the lesion is superseded by another
    • symptoms are mild but once the cornea is involved (corneal phlycenules develop as a grey amorphous infiltrate), there is pain, lacrimation and photophobia. These are most marked in tuberculo-protein induced disease

Management:

  • seek expert advice
  • steroid drops may provide symptomatic relief but it is more important to treat the underlying disease and improve the diet and surroundings of the patient
  • when found should be further investigated to discover an underlying pathology. Tuberculosis should always be excluded. Specialist centre referral may be required

Reference

  1. Rohatgi J, Dhaliwal U. Phlyctenular Eye Disease: A Reappraisal. Jpn J Ophthalmol. 2000;44:146–150.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.